Sensydia announced an oversubscribed funding round led by Colle Capital Partners to complete its ACOUSTIC-1 study and prepare for commercial launch.
- Amount
- $6M
- Announced
- 13 October 2026
- Lead
- Colle Capital Partners
- Other investors
- Orlando Health Ventures
- Use of funds
- Completion of ongoing ACOUSTIC-1 study for the Cardiac Performance System and preparation for commercial launch.
- Checked
- Announced by the company